Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events-Reference-Cited by-同舟云学术

Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events

Published:2021-04-14 Issue:4 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

O'Shea Orlagh¹,Stovold Elizabeth²,Cates Christopher J²

Affiliation:

1. School of Physiotherapy; Royal College of Surgeons in Ireland; Dublin Ireland

2. Cochrane Airways, Population Health Research Institute; St George's, University of London; London UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference181 articles.

1. Adjustable dosing with budesonide/formoterol reduces the rate of asthma exacerbations compared with fixed dosing salmeterol/fluticasone;Aalbers;European Respiratory Journal,2003

2. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma;Aalbers;Current Medical Research and Opinion,2004

3. Adjustable dosing with budesonide/formoterol achieves sustained guideline ‘well-controlled asthma‘ following step down in treatment;Aalbers;European Respiratory Journal,2005

4. Aalbers R Welte T Jorup C Adjustable maintenance dosing (AMD) with budesonide /formoterol (B/F) meets guideline-defined management goals more effectively than fixed dosing (FD) with B/F or salmeterol/fluticasone (S/FL) European Respiratory Journal 2004 24 Suppl 48 311s

5. Aalbers R Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol fluticasone propionate in asthma patients aged [greater-than or equal to]16 years: post hoc analysis of a randomised, double-blind open-label extension, parallel-group study Clinical Drug Investigation 2010 30 7 439 51

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of β2-adrenergic receptor agonist combined with corticosteroid in the treatment of children with cough variant asthma;World Journal of Clinical Cases;2023-11-06

2. Asthma and COPD: A Focus on β-Agonists – Past, Present and Future;Handbook of Experimental Pharmacology;2023

3. For adults with chronic asthma receiving inhaled corticosteroids (ICSs), how does adjunct formoterol compare with salmeterol in terms of serious adverse events?;Cochrane Clinical Answers;2021-04-22

4. For children with chronic asthma receiving inhaled corticosteroids (ICSs), how does adjunct formoterol compare with salmeterol in terms of serious adverse events?;Cochrane Clinical Answers;2021-04-22